Recording - Addressing Nitrosamines in APIs and Drugs: Analytical Strategies
Watch the recording of our webinar, held on November 7, 2014, and hosted by Shiva Analyticals, which focused on the critical topic of nitrosamines in Active Pharmaceutical Ingredients (APIs) and drugs.
Given their potential carcinogenic effects, controlling nitrosamine impurities is essential to ensure product safety.
The webinar also covered regulatory-driven extractable and leachable (E&L) studies, including a case study on inhaled and nasal products, emphasizing the importance of ensuring nitrosamine-free products to safeguard consumer health
Latest News
30.10.2026
Beyond Carbon Footprint: A Practical Guide to More Sustainable Businesses
Explore how GHG inventories, emissions verification, Life Cycle Assessment, energy management and ESG assurance support credible business sustainability.
30.10.2026
Strengthening Cotecna's Global Metals & Minerals Network Through Leadership Engagement
Mark Houchin's global visits highlight Cotecna's commitment to technical excellence and operational alignment, while focussing on strong customer partnerships worldwide.